Cargando…
Intravenous immunoglobulin treatment stabilizing a patient with Anti-PL7 antisynthetase syndrome with interstitial lung disease and eosinophilic inflammation
Antisynthetase syndrome (AS) is a rare autoimmune disease characterized by autoantibodies against aminoacyl-transfer RNA synthetase and clinical features which can include interstitial lung disease (ILD). Current available evidence of treatment is based on expert opinions and case reports. Here, we...
Autores principales: | Peshbahar, Soran, Hyldgaard, Charlotte, Bendstrup, Elisabeth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256658/ https://www.ncbi.nlm.nih.gov/pubmed/35814032 http://dx.doi.org/10.1016/j.rmcr.2022.101686 |
Ejemplares similares
-
Remarkable benefits of intravenous immunoglobulin (IVIG) in a patient with polymyositis-associated acute interstitial lung disease
por: Peshbahar, Soran, et al.
Publicado: (2020) -
Anti-PL-7 Antisynthetase Syndrome with Eosinophilic Pleural Effusion
por: Saito, Go, et al.
Publicado: (2018) -
Clinical characteristics and outcome in patients with antisynthetase syndrome associated interstitial lung disease: a retrospective cohort study
por: Jensen, Mads Lynge, et al.
Publicado: (2019) -
Syndrome in question: antisynthetase syndrome (anti-PL-7)
por: Esposito, Ana Cláudia Cavalcante, et al.
Publicado: (2016) -
14. Digital ischemia and interstitial lung disease in antisynthetase syndrome with PL-12 antibody
por: Usman Khan, Maria, et al.
Publicado: (2019)